HomeCOLOB • SWX
add
Coloplast A/S
Previous close
CHF 109.85
Year range
CHF 109.85 - CHF 109.85
Market cap
134.57B DKK
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
In the news
Financials
Income Statement
Revenue
Net income
(DKK) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 6.93B | 5.22% |
Operating expense | 2.84B | 5.62% |
Net income | 912.00M | -27.16% |
Net profit margin | 13.16 | -30.77% |
Earnings per share | 5.45 | -3.20% |
EBITDA | 2.24B | 5.92% |
Effective tax rate | 38.83% | — |
Balance Sheet
Total assets
Total liabilities
(DKK) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 729.00M | -18.00% |
Total assets | 49.15B | 2.10% |
Total liabilities | 32.21B | 0.85% |
Total equity | 16.94B | — |
Shares outstanding | 225.17M | — |
Price to book | 1.46 | — |
Return on assets | 9.70% | — |
Return on capital | 11.61% | — |
Cash Flow
Net change in cash
(DKK) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 912.00M | -27.16% |
Cash from operations | 742.00M | 128.98% |
Cash from investing | -309.00M | -7.67% |
Cash from financing | -598.00M | -121.31% |
Net change in cash | -177.00M | -555.56% |
Free cash flow | -349.12M | 90.15% |
About
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
Founded
1957
Headquarters
Website
Employees
16,741